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Usher Syndrome (USH) is the leading cause of hereditary deafblindness. It is 
characterized by hearing and vestibular impairment as well as progressive retinal 
degeneration. This syndrome has been classified into three types based on the severity 
of the symptoms. Patients affected with USH1 present the most severe symptoms. 
CADHERIN 23 (CDH23), the focus of this research, is one of the 6 genes causing 
USH1 when mutated. Previous work in zebrafish has determined that the encoded 
protein is present in an USH1 complex that preassembles at the endoplasmic reticulum 
(ER), a subcellular compartment. When the cdh23 gene is mutated, the USH1 complex 
assembly and trafficking are disrupted, which leads to a cellular response called ER 
stress. It was also shown that inner ear hair cell and retinal cell death increase in the 
cdh23 mutants. As a first step to understand if ER stress is the cause of increased cell 
death in the cdh23 zebrafish mutants, I characterized the molecular pathways activated 
by ER stress and tested if FDA approved drugs targeting specific components of the 
activated pathways could lower ER stress and decrease cell death. I found that the Ire1 
pathway is potentially activated in the inner ear hair cells and that the Perk pathway is 
activated in both the inner ear hair cells and the retinal cells of cdh23 mutants. 
Furthermore, these mutants showed decreased levels of ER stress when treated with 
FDA approved drugs. The preliminary data presented in this thesis expand the current 
understanding of the molecular mechanism leading to USH1 and point toward 
directions for future research. 
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1. Introduction 
1.1 Usher syndrome 
Usher syndrome (USH) is the leading cause of deafblindess in the United States 
and affects approximately 1/6000 individuals (Kimberling et al., 2010). Patients present 
with hearing and vestibular impairment, as well as vision loss through progressive 
retinal degeneration, known as retinitis pigmentosa (RP) (Yan et al., 2010).  
There are three clinical types of USH based on the severity of the symptoms. 
USH Type 1 (USH1) is the most severe form of the disease. It is characterized by 
congenital, profound deafness, balance problems, and progressive RP that has an onset 
within the first decade of life (Mathur et al., 2015). USH2 is the most common clinical 
type (USHbases). Patients with USH2 have moderate to severe congenital hearing loss, 
normal vestibular function, and an onset of RP in the second decade of life (Mathur et 
al., 2015). USH3 is more rare. Loss of hearing and onset of RP are progressive, and 
vestibular dysfunction is variable (Mathur et al., 2015).  
Table 1: USH genes and proteins. 
 
USH type Gene name Protein name 
USH1 MYO7A MYOSIN VIIA 
 USH1C HARMONIN 
 CDH23 CADHERIN 23 
 PCDH15 PROTOCADHERIN 15 
 USH1G SANS 
 CIB2 CIB2 
USH2 USH2A USHERIN 
 GPR98 VLGR1 
 DFNB31 WHIRLIN 
USH3 USH3A CLRN1 
 USH3B HARS-1 
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 So far, researchers have been able to identify 11 genes that cause the disorder. 
Six genes are linked to USH1, three to USH2, and two to USH3 (Table 1) (Mathur et 
al., 2015). More genes related to USH remain to be discovered.  
The focus of this thesis will be on USH1, and specifically on one of the 
causative genes, CDH23, and its effects when mutated.  
To date there is no cure for USH1 patients. Using zebrafish as an animal model 
for USH1, this thesis aimed first to characterize the molecular mechanisms leading to 
USH1 and then to select and test FDA approved drugs that could potentially be used to 
treat symptoms in human USH1 patients.  
1.2 Molecular basis for deafness and blindness in USH1     
 USH1 severely affects 
both inner ear and retinal 
function. To gain understanding 
about what exactly is happening 
in USH1, researchers have 
explored the effects of USH1 
mutations in model organisms. A 
substantial amount of progress 
has been made with a particular 
focus on the inner ear.  
The hair cells are the sensory cells of the inner ear (Figure 1A). They can sense 
 
Figure 1: Hair cell of the bullfrog inner ear (A). Mechanoreceptor 
of the hair cell (B). Source: Prof. Jim Hudspeth, Rockefeller 
University and Prof. Peter Gillespie, OHSU. http://www.labex-
celtisphybio.fr/active-mechanosensitivity-by-hair-cells-in-the-inner-
ear/ 
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motion and sound through a structure called the mechanoreceptor (Arrow in Figure 1A 
and Figure 1B), and transmit this information to the brain.  
The mechanoreceptor is made up of a single kinocilium composed of 
microtubules and multiple actin-based stereocilia that are bound together in a highly-
organized fashion (Figure 1B). The latter form the hair bundle (Mathur et al., 2015). In 
response to sound, movement or gravity, the mechanoreceptor moves, which induces 
the opening of ion channels at the tip of the stereocilia (Mathur et al., 2015). A 
subsequent influx of ions leads to changes in membrane potential and release of 
neurotransmitters at synapses. The conversion of the mechanical stimulus into an 
electrical response is a process known as mechanotransduction.  
The integrity of the hair bundle is essential. Any change in its morphology will 
disrupt hair cell function, which can lead to deafness. The USH1 proteins are 
responsible for maintaining the correct morphology of the hair bundle by forming links 
between the stereocilia (Figure 5A). Therefore, if one USH1 protein is missing or the 
USH1 complex is unable to form, it can compromise the integrity of the hair bundle and 
disrupt hair cell function (Mathur et al., 2015). 
Many studies have been done to understand the role of USH1 proteins in inner 
ear hair cell function, but less is known about their role in visual function. RP is caused 
by a degeneration of the photoreceptor cells of the retina. Photoreceptors are the sensory 
cells of the eye (Figure 2) and are responsible for converting light to sensory  
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 information, a process called 
phototransduction. In macaque monkeys 
and mice, researchers have found that 
USH1 proteins localize at the inner and 
outer segments of the photoreceptors and in 
the photoreceptor synapses, respectively 
(Ahmed et al., 2008; Reiners et al., 2005; 
Sahly et al., 2012). Despite these results, 
the exact function of the USH1 proteins in 
the photoreceptor cells is still not clear. 
However, it has been described that mutations in some Ush1 genes can lead to 
photoreceptor death and vision impairment in mice at several months of age (Lentz et 
al., 2010). Additionally, one USH1 gene, MYO7A, has been shown to have a variety of 
functions within the mouse retina (Williams and Lopes, 2011). Specifically, the absence 
of MYO7A in photoreceptors leads to abnormally high levels and accumulation of 
opsin, which are light sensitive proteins found in the retina. This suggested that 
MYO7A may play a role in opsin transport and thus light sensitivity in mice (Sakai et 
al., 2011). 
1.3 Zebrafish model 
 Different animal models have been developed to characterize the molecular 
mechanisms underlying USH but zebrafish is now emerging as an excellent organism to 
study this syndrome. First, fertilization is external, allowing researchers to follow early 
stages of development. Second, many eggs are laid at once, giving an abundance of 
 
Figure 2: Photoreceptor cells from the retina. 
Adapted from http://thebrain.mcgill.ca/ 
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offspring to work with. Third, embryos are transparent, allowing researchers to visually 
track their overall development or the development of a particular organ. Fourth, 
zebrafish develop very fast. By 5 days post-fertilization (dpf), the visual and vestibular 
systems of the zebrafish larvae are already functional (Figure 3). Fifth, as in humans, 
zebrafish are diurnal animals. They are awake during the day and sleep at night. Finally, 
zebrafish mutants for ush1 genes present with balance and visual defects that are 
comparable to symptoms in human USH patients. 
 
1.3.1. ush1 mutants 
Mutations in four ush1 genes, ush1c, cdh23, myo7aa and pcdh15a, have been 
studied and characterized in zebrafish. Mutants for each of these genes all display 
hearing and vestibular impairment. These impairments are caused by changes in the hair 
bundle morphology that result in a splayed and/or bent phenotype of the bundle (Figure 
4) (Blanco Sánchez et al., 2014; Ernest et al., 2000; Phillips et al., 2011; Seiler et al., 
2005; Söllner et al., 2004). Additionally, ush1c, cdh23, and myo7aa mutants have been 
found to have fewer hair bundles than their wild-type siblings (Blanco Sánchez et al., 
2014; Phillips et al., 2011). Although more commonalities are seen with the ush1 
mutants in respect to the inner ear, past research has illuminated the differences between 
 
Figure 3: Zebrafish larvae at 5 dpf. Red arrow points to the eye. Blue arrow points to the inner ear.  5 dpf larvae 
are approximately 4 mm long. Source: Dr. Aurélie Clément.   
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these ush1 mutants in terms of their visual systems. Retinal degeneration and lessened 
visual function have been shown in ush1c and myo7aa mutants through, respectively, 
elevated photoreceptor cell death and a reduced optokinetic response, which assays the 
ability of the fish to track a moving object visually (Wafsy et. al., 2014; Phillips et. al., 
2011). Unlike the ush1c and myo7aa mutants, effects on vision have not been observed 
in cdh23 or pcdh15a mutants. Immunohistochemistry experiments have not shown 
photoreceptor cell degeneration for either of these mutants and both maintain wild-type 
responses to the optokinetic response test (Glover et. al., 2012; Seiler et. al., 2005).  
1.3.2. cdh23 mutant 
Analysis of the cdh23 mutant via measurements of microphonic potentials has 
revealed reduced or even absent mechanotransduction from the hair cells of a 
neuromast, a sensory organ of fish within the lateral line system (Nicolson et. al., 1998). 
Researchers found that when stimulated, the cdh23 mutant hair cells do not respond 
normally and cannot transduce the sensory signals (Nicolson et al., 1998). Behavioral 
analysis of cdh23 mutants show a circling phenotype in response to a startle, which is a 
possible consequence of their reduced lack of mechanotransduction (Glover et al., 2012; 
Nicolson et. al., 1998; Söllner et al., 2004). This circling behavior is typical of mutants 
with vestibular dysfunction. 
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In mutants carrying nonsense or missense mutations in the cdh23 gene, balance 
defects are due to a loss of structural integrity of the hair bundle and defective 
development of this organelle. 
Specifically, the stereocilia are 
splayed and/or bent and a decrease 
in the number of hair bundles 
formed is observed (Figure 4) 
(Blanco Sánchez et al., 2014; 
Nicolson et al., 1998; Söllner et al., 
2004). An increase in hair cell 
death is also observed (Blanco 
Sánchez et al., 2014). 
In the zebrafish retina, 
cdh23 is expressed in amacrine 
cells, interneurons of the retina, from 70 hpf and continuing throughout adulthood 
(Glover et al., 2012). However, no expression is found in the photoreceptors (Glover et 
al., 2012). Additionally, mutant larvae do not display retinal dysfunction or 
degeneration, and they respond normally to the optokinetic response test (Glover et al., 
2012). 
 
 
Figure 4: Phalloidin labeling of the anterior macula in 5dpf 
zebrafish inner ear. Red arrow points to highly organized wild-
type hair bundles (A). Blue arrow points to a hair bundle with 
splayed stereocilia in cdh23 mutants (B). Source: Blanco 
Sánchez et al., 2014.  
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1.4. Molecular mechanisms leading to abnormal hair bundle development in ush1 
zebrafish mutants  
A recent study shows that Ush1 proteins, Cdh23, Harmonin and Myo7aa, 
congregate together to form a complex at the endoplasmic reticulum (ER) (Blanco 
Sánchez et al., 2014). The ER is a subcellular compartment surrounding the nucleus 
where transmembrane proteins and proteins that are secreted from the cell are 
synthesized before they traffic to their final location. Once it is pre-assembled, the Ush1 
complex traffics towards the mechanoreceptor, where it will accomplish its function. 
However, mutations in one or more of the genes encoding Ush1 proteins, prevent 
formation of the complex and consequently its transport from the ER. As a result, the 
proteins accumulate in the ER, creating ER stress (Figure 5) (Blanco Sánchez et al., 
2014). 
 
 
Figure 5: Schematic of Ush1 protein localization in the inner ear hair cells from wild-type (A) and ush1  
mutant zebrafish (B). Blue arrow indicates protein trafficking from the ER toward the mechanoreceptor. 
Source: Dr. Aurélie Clément. 
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One possible consequence of ER stress is cell death (Hertz, 2012). This latter 
process is known to be responsible for deafness and blindness (Mathur et al., 2015). In 
zebrafish mutants for ush1 genes, an increase of inner ear hair cell and photoreceptor 
cell apoptosis, a programmed cell death, has been observed (Blanco Sánchez et al., 
2014; Phillips et al., 2011). At this point, a direct link between ER stress and cell death 
has not been established. Making a first link between these events is the purpose of my 
project. 
1.5 Project Rationale  
In zebrafish, accumulation of Ush1 proteins, including Cdh23, at the ER creates 
a stress on this subcellular compartment, called ER stress (Blanco Sánchez et al., 2014). 
There is always a basal level of ER stress. When the load of abnormal proteins is too 
high and these proteins accumulate, the stress exceeds its threshold. One response a cell 
has to this ER stress is the activation of the Unfolded Protein Response (UPR).  
The UPR is made up of three pathways, Ire1, Perk, and Atf6, that can work 
individually or together, depending on the cause of activation (Figure 6). My work will 
focus on the Ire1 and Perk pathways.  
For these two pathways, activation occurs through phosphorylation of the Ire1 
and Perk proteins. Phosphorylation is a reversible modification of a protein that leads to 
a specific cascade of events. In the case of the UPR, those events lead to a decrease in 
translation and/or a degradation of proteins to decrease the load of proteins present at 
the ER. If the cell cannot resolve ER stress, it will enter into apoptosis.  
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Because any one or a combination of the three UPR pathways can be activated 
by ER stress, characterization of the exact molecular pathways implicated in the steps 
between ER stress activation and cell death would be essential to finding a specific drug 
treatment. Currently, FDA approved drugs are used to prevent ER stress in other 
diseases, such as Alzheimer’s and Parkinson’s. Similar drugs could be used in treatment 
of USH1. This is critical because, to date, there are no drugs available to treat USH1.  
In a recent study, Hu et al. (2016) investigated the molecular pathways activated 
by ER stress and leading to hair cell apoptosis in a Cdh23 mutant mouse. Their results 
indicate that the Perk pathway is activated in this USH1 mutant. The researchers used 
the ER stress inhibitor Salubrinal, to inhibit dephosphorylation of eIF2α selectively, an 
active component of the Perk pathway. They found that there is significantly less hair 
 
Figure 6: Schematic of the three UPR pathways. Source: http://www.robertlfurler.com/2012/12/07/life-
cycle-of-a-cell/ 
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cell death and better hearing in the Cdh23 mutant mice that received the drug than in the 
mice that did not.  
 The results of this study relate very closely to my project. However, the Hu et al. 
(2016) research focused on the inner ear hair cells and only addressed the question of 
whether the PERK pathway was activated in the Cdh23 mouse mutants. My project 
aimed to characterize in more depth the cascades of events triggered in the zebrafish 
cdh23 mutants. Specifically, I not only examined both the Perk and Ire1 pathways, but I 
also studied them in different cell types, the inner ear hair cells and the retinal cells. 
Because hearing and vestibular impairment in conjunction with vision loss are 
characteristic of USH1, it was important to characterize the activated UPR pathways in 
cells of both the inner ear and retina in zebrafish.  
As mentioned above, analyzing the Perk and Ire1 pathways in both the inner ear 
and the eye of the cdh23 mutants was the first goal of my project. Using these findings, 
my second goal was to test FDA approved drugs affecting the activated UPR pathways 
and to assay their effects on behavior as well as hair bundle integrity and development.  
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2. Materials and Methods 
2.1 Husbandry 
 Zebrafish strains used were cdh23tj264 (Söllner et al., 2004), cdh23 
tj264;eif2αsa10155 and cdh23tj264;Tg[myo6b:Kdel-crimson]b1319. Zebrafish were raised in 
a 14-hour light and 10-hour dark cycle and maintained at 28.5°C. Eggs were collected 
following fertilization and stored in embryo medium until 5 dpf. 0.003% 1-phenyl-2-
thiourea was added to cdh23tj264 mutants before 25 hours post fertilization (hpf) to 
prevent pigmentation and allow study of the retina. All analyses were done at 5 dpf, 
when vestibular and visual systems are known to be functional. All experiments 
followed protocols approved by the University of Oregon Institutional Animal Care and 
Use Committee. 
 2.2 Immunohistochemistry  
 Larvae were anesthetized and fixed in BT fix solution (4% paraformaldehyde, 
4% sucrose, 0.15mM CaCl2 in phosphate buffer saline (PBS)) for 24-48 hours, then 
washed 4 times 5-min in 0.1% Tween-20 in PBS (PBT). Larvae were permeabilized in 
2.5% Tween-20 at room temperature for 18 hours, followed by a 15-min acetone crack 
at -20°C. Following 3 times 5-min washes in PBT, samples were blocked overnight in 
PBS blocking solution (PBS, 5% goat serum, 5% bovine serum albumin) at 4°C and 
then incubated overnight at 4°C in primary antibody solution (PBS blocking solution + 
primary antibody) (Figure 7). Primary antibodies used were rabbit anti-Ire1 (Cell 
Signaling), rabbit anti-Phospho-Ire1 (Novus Biologicals), rabbit anti-Perk (Cell 
Signaling), rabbit anti-Phospho-Perk (Cell Signaling), mouse anti-eiF2α (Santa Cruz),  
 
 
13  
 rabbit anti-
Phospho-eiF2α 
(Cell Signaling). 
Primary antibodies 
were all added at a 
1:400 dilution in 
PBS blocking 
solution. For double 
immunolabeling, 
both primary 
antibodies were 
added concurrently. 
 Unbound primary antibodies were removed by 4 times 30-min washes in PBT. 
Following an overnight incubation at 4°C in PBS blocking solution, secondary 
antibodies, biotinylated horse anti-rabbit (Vector Laboratories; 1:500), were added 
overnight at 4°C (Figure 7). Unbound secondary antibodies were removed by 4 times 
30-minute washes in PBT.  
 For the detection step, the Vectastain ABC Elite kit (Vectorlabs) was used to 
amplify the signal and allow for better visualization of proteins. This amplification 
system utilizes the ability of the Avidin and Biotin molecules to form complexes. Horse 
radish peroxidase (HRP) conjugated-Biotin and Avidin molecules were pre-incubated in 
PBS blocking solution (AB solution) at a 1:1:100 ratio for 20 minutes at room 
 
Figure 7: Schematic representation of immunohistochemistry. The primary 
antibody binds to a specific protein. Secondary antibodies specifically recognize 
and bind to the primary antibodies. The signal results from a catalytic reaction 
when a substrate is added. Adapted from: 
http://www.leinco.com/immunohistochemistry 
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temperature. The AB solution was then added to the samples for 25 minutes at room 
temperature. Following 2 PBT rinses and 4 times 5-min washes, the samples were 
incubated for 25-min with a fluorescent substrate, cyanine-3 (TSA kit, Vector 
Laboratories), diluted at 1:75 in amplification buffer (PBT, 0.006% H2O2). The 
catalytic reaction was stopped by 3 times 5-min washes in PBT.  
 In the case of single immunolabeling (only one protein detected), samples were 
stored in Vectashield (Vectorlabs) at 4°C. In the case of double immunolabeling (two 
proteins detected), the catalytic reaction was stopped by 4 times 5-min washes in PBT 
and the HRP enzyme was inactivated by incubation in 0.1 M hydrochloric acid for 10-
min. Following 6 times 5-min PBT washes, larvae were post-fixed for 20-min in BT fix 
solution. After 4 times 5-min PBT washes, 1 drop of avidin solution was added for 1-
hour and removed. 1 drop of HRP conjugated-Biotin was then added for 1-hour. 
Samples were washed twice in PBT for 5-min and incubated in PBS blocking solution 
overnight. Next, secondary antibodies, biotinylated horse anti-mouse (Vector 
Laboratories; 1:500), were added. Steps for detection were the same as described above, 
with fluorescein as a substrate. 
2.3 Genotyping 
 To genotype the double mutants cdh23 tj264;eif2αsa10155, larvae were anesthetized 
in Mesab and cut in two. Heads were immersed in BT fix for 48 hrs at 4°C and then 
phalloidin-labeled (see below section). Tails were incubated 20-min in a DNA lysis 
buffer (NaOH 25mM, EDTA 0.2mM in H2O) at 95°C to extract genomic DNA 
(gDNA). A polymerase chain reaction (PCR) was then run using the GoTaq system 
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(Promega) to obtain the amplicon that would be sequenced (Genewiz). Sequences of the 
primers and PCR conditions are described in Table 2, 3 and 4.  
 
 
 
 
 
 
  
 
 
 
 
 
tj64a-F2 5'-ACTCCAGTTGGGACGTCAGT-3' 
tj64a-R2 5'-TTGTATTGCTTGATTGGTATGG-3' 
eif2α.f2 5'-CACTGCAGTTCTTGTCACCG-3' 
eif2α.r2 5'-CAATGTGCACATTGCGATGTTGATGC-3' 
Table 4. Primer sequences for cdh23 tj264 and eif2αsa10155. 
 
2.5 Actin labeling 
 Steps were the same as for an immunolabeling, but phalloidin was used in place 
of a primary antibody and incubated overnight at 4°C (0.08 unit/ul phalloidin) 
(Thermofisher Scientific) in PBS blocking solution). Phalloidin solution was removed 
by 4 times 30-min washes in PBT and larvae were stored in Vectashield. 
 
PCR Step Temperature Time  
1 95 °C 5 min 
2 95 °C 30 s 
3 60 °C 20 s 
4 72 °C 30 s 
5        Go back to step 2, 39 times  
6 72 °C 5 min 
7        END  
Table 2. PCR conditions for amplification of the DNA fragment for cdh23 tj264.
  
 
PCR Step Temperature Time  
1 95 °C 2 min 
2 95 °C 20 s 
3 67.5 °C 30 s 
4 72 °C 30 s 
5        Go back to step 2, 34 times  
6 72 °C 5 min 
7        END  
Table 3. PCR conditions for amplification of the DNA fragment for eif2αsa10155.
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2.6 Behavior Assay 
 The behavior of treated and untreated mutants and siblings was assessed at 5 
dpf using the Startle Response Test. This test was performed by tapping the side of the 
dish and observing the larvae’s response.   
2.7 FDA Approved Drugs  
cdh23 tj264;eif2αsa10155 and cdh23tj264;Tg[myo6b:Kdel-crimson]b1319 larvae 
were incubated with dimethylsulfoxide (DMSO) or FDA approved drugs, SP600125 
and Losmapimod, from 3 dpf for 48 hours or from 4 dpf for 24 hours. DMSO, 
SP600125 and Losmapimod were diluted in EM at a concentration of 10µM. Larvae 
were then fixed in BT fix at 5 dpf. 
2.8 Imaging  
 Images of labeled larvae were obtained using a LSM510 Zeiss confocal 
microscope. Larvae were mounted laterally in Vectashield between slide and coverslip. 
Scans of the inner ear anterior macula and of the retina were done using a 63x objective. 
ImageJ (v. 1.51) was used to measure pixel intensity and count hair bundles and hair 
cells. 
2.9 Statistical Methods  
 A student’s t-test was performed to test if the difference between sets of data 
was significant. Each t-test gave a p-value, which is the calculated probability that two 
data sets are different due to random chance. If the p-value was less than 0.05 the data 
were said to be significant (* in graphs). If the p-value was less than 0.01 the data were 
said to be highly significant (** in graphs). If the p-value was more or equal to 0.05 the 
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data were said to be non significant (ns in graphs). All means for intensity were 
normalized.  
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3. Results  
 
3.1 Identification of the UPR pathways activated in the cdh23 mutant 
 The first goal of this research was to identify the UPR pathways activated in the 
cdh23 zebrafish mutants. There are three UPR pathways named after the first protein 
activated for each of them, Ire1, Perk, and Atf6. I focused on the Ire1 and Perk 
pathways.  
Both the Ire1 and Perk pathways are activated by phosphorylation. Therefore, by 
comparing the levels of phosphorylated Ire1 and Perk with their total amount utilizing 
immunohistochemistry, in both cdh23 mutants and their siblings, I was able to assay 
activation.  
3.1.1 Ire1 pathway 
To determine the amount of phosphorylated Ire1 and total Ire1 in the inner ear 
hair cells, I measured the intensity of the signal in all the hair cells of one of the sensory 
patches, the anterior macula 
(Figure 8). In the eye, the levels 
were determined for 1) all retinal 
cell types and 2) the 
photoreceptors only (Figure 9). 
For each larva labeled, images 
were acquired from both the hair 
cells of the anterior macula and 
 
Figure 8: Optical section of the anterior macula of a cdh23 
wild-type sibling (A). Yellow dashed line encloses the hair cells. 
DIC image of the same section (B). Scale bar: 10 µm. 
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the retinal cells. Labeling for Ire1 and phosphorylated Ire1 (PhosphoIre1) were repeated 
three times.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the hair cells of the anterior macula, there was an apparent increase of the 
level of phosphorylated Ire1 in the mutants, but this increase was not significant 
(Figures 10 and 11). This suggests that, with the current data, the Ire1 pathway might be 
activated in the inner ear hair cells of cdh23 mutants. 
 
Figure 9: Optical section of the retina of cdh23 wild-type 
sibling (Sib). (A) Perk labeling. (B) DIC image of the same 
section. Yellow box delimits the retinal cells for which intensity 
will be measured. Blue box delineates the photoreceptor cells. 
Scale bar: 10 µm. 
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Figure 10: Levels of Ire1 in hair cells of the anterior macula. Ire1 labeling in sibling (A, n=11) and cdh23 mutant 
(B, n= 12). PhosphoIre1 labeling in siblings (C, n=16) and cdh23 mutant (D, n= 17). Scale bar: 10 µm.  
 
 
Figure 11: Quantification of Ire1 and PhosphoIre1in the inner ear hair cells. Black lines 
represent ± S.E.M. ns = not significant. 
 
 Analysis in the whole retina showed no significant difference between the levels 
of phosphorylated Ire1, but did show a significant decrease of the total amount of Ire1 
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between cdh23 and their siblings (Figure 12 and Figure 13A). Similarly, no significant 
change was observed within the photoreceptors (Figure 13B). This likely indicates that 
the Ire1 pathway is not activated in the retina of the cdh23 zebrafish mutant.  
 
Figure 12: Levels of Ire1 in the retina. Ire1 labeling in sibling (Sib) (A, n=11) and cdh23 mutant  
(B, n= 15). PhosphoIre1 staining in siblings (C, n=15) and cdh23 mutant (D, n= 16). Scale bar: 10 µm. 
 
Figure 13: Quantification of Ire1 and PhosphoIre1 in the retina (A) and photoreceptors (B). Black lines represent 
± S.E.M. * p <0.05, ns = not significant. 
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3.1.2 Perk Pathway 
The activation of this pathway was investigated via the activation of two 
proteins, Perk and a downstream target of this kinase, Eif2α. The amounts of 
phosphorylated Perk and total Perk and phosphorylated Eif2α and total Eif2α in the hair 
cells and retinal cells were determined as explained above. Labelings for Perk, 
phosphorylated Perk (PhosphoPerk), Eif2α, and phosphorylated Eif2α (PhosphoEif2α) 
were repeated twice. 
 Analysis of the anterior macula showed significant changes between the levels 
of phosphorylated Perk and total Perk in the cdh23 mutants compared to siblings 
(Figure 14 and Figure 15). This result suggests that in cdh23 mutants the Perk pathway 
is activated in the hair cells.  
 
Figure 14: Levels of Perk in hair cells of the anterior macula. Perk labeling in sibling (Sib) (A, n=8) and cdh23 
mutant (B, n= 8). PhosphoPerk labeling in siblings (C, n=8) and cdh23 mutant (D, n= 11). Scale bar: 10 µm. 
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Figure 15: Quantification of Perk and PhosphoPerk in hair cells. Black lines represent ± S.E.M. * 
p<0.05, ns = not significant. 
 
 Analysis in the retina showed a highly significant difference between the levels 
of phosphorylated Perk or in the total amount of Perk proteins (Figure 16 and Figure 
17A). However, no significant difference between the levels of phosphorylated or total 
Perk was found in the photoreceptors (Figure 17B). These results indicate that, with the 
current data, there is activation of the Perk pathway in the eye, but not in the 
photoreceptors of cdh23 mutant zebrafish.   
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Figure 16: Levels of Perk in the retina. Perk labeling in sibling (Sib) (A, n=8) and cdh23 mutant (B, n= 8). 
PhosphoPerk staining in siblings (C, n=10) and cdh23 mutant (D, n= 11). Scale bar: 10 µm. 
 
Figure 17:  Quantification of Perk and PhosphoPerk in the retina (A) and photoreceptors (B). Black lines  
represent ± S.E.M. ** p <0.01, ns = not significant 
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 Labeling for Eif2α 
and PhosphoEiF2α was 
conducted in the same larvae. 
In the hair cells of the anterior 
macula, I found a highly 
significant increase in the 
levels of phosphorylated 
proteins in the mutants 
compared to the total amount 
of Eif2α (Figure 18 and 
figure 19). This is not a 
surprising result given the 
Perk pathway is activated in these cells in the cdh23 mutants. 
 
 
  
 
 
 
 
 
 
 
 
Figure 18: Levels of EiF2α in hair cells of the anterior macula. 
EiF2α labeling (red) in siblings (Sib) (A, n=9) and cdh23 mutants 
(B, n= 11). PhosphoEiF2α labeling (green) in siblings (C, n=9) and 
cdh23 mutants (D, n= 11). Scale bar: 10 µm.   
 
Figure 19: Quantification of EiF2α and PhosphoEiF2α in hair cells. 
Black lines represent ± S.E.M. ** p <0.01, ns = not significant.    
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 In the various cells of the retina, including the photoreceptors, my experiments 
showed a significant increase in the levels of phosphorylated EiF2α in cdh23 mutants 
(Figure 20 and Figure 21). This is not surprising given that the Perk pathway is 
activated in this tissue in the cdh23 mutants. 
 
 
 
Figure 20: Levels of EiF2α in the retina. EiF2α labeled (red)) in siblings (Sib) (A, n=9) and cdh23 mutant (B, 
n= 11). PhosphoEiF2α (green) in siblings (C, n=9) and cdh23 mutant (D, n= 11). Scale bar: 10 µm. 
 
Figure 21: Quantification of EiF2αand PhosphoEiF2α in the retina (A) and photoreceptors (B). Black lines 
represent ± S.E.M. * p<0.05, * p<0.01, ns = not significant. 
 
 
Overall, these results indicate that, in zebrafish, at this stage of development, the 
Ire1 pathway might be activated in the inner ear hair cells of cdh23 mutants and the 
Perk pathway is activated in the inner ear hair cells and retinal cells.   
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3.2 Effect of FDA approved drugs blocking different branches of the Ire1 pathway in 
cdh23 mutants 
From the immunohistochemistry studies, I found not only that the Perk pathway 
is activated in the inner ear hair cells of the cdh23 mutants, but that the Ire1 pathway 
may also be activated in this tissue. These preliminary results allowed me to select 
among FDA approved drugs that can specifically inhibit a UPR pathway or part of a 
UPR pathway. 
 
3.2.1 Effects of FDA approved drugs on ER stress  
To assay the efficiency of the FDA approved compounds chosen, I measured the 
amount of ER stress in treated and untreated cdh23 mutants and siblings using the 
cdh23tj264;Tg[myo6b:Kdel-crimson]b1319 mutant line. This line contains a transgene 
that allows expression of a ER stress marker specifically in the hair cells. The 
fluorescence of this marker allows quantification of ER stress.  
For this assay, I treated mutant cdh23tj264 and their siblings with the FDA 
approved drugs Losmapimod and SP600125. Both drugs target the Ire1 pathway, but at 
two different levels. Losmapimod targets the mitogen-activated protein kinase (MAPK) 
branch of the pathway, whereas SP600125 targets the c-Jun N-terminal kinase (JNK) 
branch. Two separate experiments were carried out to assess the both drug’s effects 
over a different amount of time.  
In the first experiment, cdh23 mutants and siblings were exposed to 
Losmapimod or SP600135 from 4 dpf for 24 hrs (Figure 22A-F). No significant 
difference in the level of ER stress was observed between untreated and Losmapimod 
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treated larvae (Figure 22C,D,G). However, cdh23 mutants treated with SP600125 
showed a highly significant decrease in the level of ER stress when compared to 
untreated mutants (Figure 22E-G). Interestingly, the level of ER stress was comparable 
to this of siblings treated or not with SP600125. These results support the hypothesis 
that the Ire1 pathway is activated in the inner ear hair cells. 
 
Because it is possible that longer exposure, or exposure at an earlier stage in 
development leads to a stronger effect on the outcome of ER stress, I ran a second 
experiment where 3 dpf cdh23 mutants and siblings were exposed for 48 hrs to 
Losmapimod or SP600125. Both sibling and mutant larvae that received SP600125 
were necrotic and/or dead at 5 dpf. I was therefore unable to obtain data for this drug at 
this time point. However, I was able to analyze the level of ER stress in the larvae 
treated with Losmapimod (Figure 23). I did not find a significant decrease in the level 
 
 
Figure 22: ER Stress level in the hair cells of the anterior macula. DMSO (control) treated siblings (A) and  
cdh23 mutants (B). Losmapimod treated siblings (C) and cdh23 mutants (D). SP600125 treated siblings (E) and 
cdh23 mutant (F). (A-F) Actin in red, ER Stress marker in green. Yellow dashed lines enclose single hair cells. 
 (G) Average intensity (pixels/µm) per hair cell for each drug condition. Black lines represent ± S.E.M. 
 ** p <0.01; ns = not significant. Scale bar: 10 µm. 
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of ER stress in cdh23 mutants that received Losmapimod compared to mutants that did 
not receive the drug (Figure 23E). 
 
 
 
 
3.2.2 Effects of FDA approved drugs on mechanoreceptor integrity and behavior  
 cdh23 mutants present with disrupted hair bundle morphologies (Blanco 
Sánchez et al., 2014; Nicolson et al., 1998; Söllner et al., 2004) and circle or do not 
move as a response to the startle response test. Therefore, I also analyzed the behavior 
 
Figure 23: ER Stress level in the hair cells of the anterior macula. DMSO (control) treated sibling (A) and 
cdh23 mutant (B). Losmapimod treated sibling (C) and cdh23 mutant (D). (A-D) actin in red, ER Stress 
marker in green. Yellow dashed lines enclose single hair cells. (E) Average intensities (pixels/µm) per hair cell 
for each drug condition. (H). Black lines represent ± S.E.M. ns = not significant. Scale bar: 10 µm. 
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and the hair bundle integrity of cdh23 mutants treated with Losmapimod at 3 dpf for 48 
hrs and 4 dpf for 24 hours or with SP600125 at 4 dpf for 24 hours.  
Behavior was observed prior to genotyping and was evaluated with the startle 
response test, which assays vestibular function and evaluates the ability of the larvae to 
swim away from sound or vibration (Kimmel et al., 1974; Zeddies and Fay, 2005). 
After genotyping, I found that larvae that responded to the startle by swimming  
away were wild-type or 
heterozygous, and that larvae 
unresponsive to the startle or 
would occasionally circle were 
homozygous mutants (Table 5 
and 6). Importantly, I did not 
observe a rescue of the mutant 
behavior in mutants treated with Losmapimod or SP600125 at either time point. 
 
 Following the behavior 
analysis, siblings and cdh23 
mutants treated with 
Losmapimod or not from 3 dpf 
were labeled with phalloidin to 
allow examination of the hair 
bundles. For this analysis, the 
 Wild-type 
like behavior 
USH1 like 
behavior 
DMSO siblings 18 0 
DMSO cdh23 mutants 0 6 
Losmapimod siblings 34 1 
Losmapimod cdh23 
mutants 
0 8 
Table 5. Behavior analysis of cdh23 siblings and mutants 
treated with Losmapimod at 3 dpf for 48 hrs. Wild-type like 
behavior refers to responding to a startle or poke by swimming 
away. USH1 like behavior means circling or no response after 
startle or poke.  
 Wild-type 
like behavior 
USH1 like 
behavior 
DMSO siblings 11 0 
DMSO cdh23 mutants 0 7 
Losmapimod siblings 11 0 
Losmapimod cdh23 
mutants 0 11 
SP600125 siblings 10 1 
SP600125 cdh23 mutants 0 10 
Table 6. Behavior analysis of cdh23 siblings and mutants 
treated with Losmapimod or SP600125 at 4 dpf for 24 hrs. 
Wild-type like behavior refers to responding to a startle or 
poke by swimming away. USH1 like behavior means circling 
or no response to startle or poke.  
 
 
31  
larvae were mounted laterally but slightly tilted to better visualize the whole anterior 
macula.  
Both cdh23 siblings and mutants display a range of hair bundle phenotypes 
(Figure 24). These phenotypes were examined in detail and recorded to allow 
assessment of the differences between treated and untreated cdh23 mutants and siblings. 
I counted the total numbers of hair 
bundles and hair cells in the anterior 
macula and extensively examined the 
morphology of the hair bundles 
within a predetermined section of the 
anterior macula (Figure 25). Despite 
a small increase in the amount of hair 
bundles and hair cells in 
Losmapimod treated cdh23 mutants versus untreated mutants, the differences were not 
significant (Figure 26A,B,D,E and Figure 27A,B). Similarly, although cdh23 mutants 
treated with Losmapimod had more wild-type like hair bundles and fewer splayed hair 
bundles compared to untreated mutants, there was no significant rescue of the hair 
bundle morphology (Figure 27C).  
 
Figure 24: Range of hair bundle phenotypes. WT hair 
bundle phenotype (A). cdh23 mutant hair bundle 
phenotypes: extreme splay (B), splay (C), slight splay 
(D), two-prong (E), hook (F), extreme hook (G), 
combination of morphologies (hook and splay) (H). 
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 3.3 Effect of inhibition of the Perk pathway on behavior and hair bundle integrity in 
cdh23 mutants 
To further investigate the Perk pathway, I took advantage of the genetics and 
utilized a mutant line carrying not only a mutation in cdh23 but also in eif2α, a gene 
encoding a downstream component of the Perk pathway, directly activated by Perk. The 
mutation in eif2α should prevent its activation and therefore the triggering of the 
downstream events, thus blocking the Perk pathway. With this tool, I specifically 
wanted to see if inhibition of the Perk pathway in the cdh23 mutants would lessen or 
alleviate the hair bundle morphology phenotype. The strategies used to quantify hair 
bundles and hair cells and analyze hair bundle morphology were the same as described 
above.   
No significant difference was observed in the number of hair bundles and hair 
cells between cdh23 mutants and cdh23;eiF2α double mutants (Figure 27A,B). 
Although the number of wild-type like hair bundles is higher in double mutants 
 
Figure 25: Anterior macula of a cdh23 mutant. Red half circle refers to the section of the macula 
analyzed for hair bundle morphology. Numbers refer to how counting was done: 1 and 2 are bundles, 3 is a 
hair cell without a bundle. Yellow arrow points to a splayed hair bundle.  Scale bar: 10 µm. 
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cdh23;eiF2α compared to cdh23 mutants, the difference was not significant (Figure 
27). To summarize, I did not observe a significant rescue of the cdh23 mutant 
phenotypes from blocking the Perk pathway.  
 
3.4 Effect of combined inhibited Ire1 and Perk pathways on hair bundle integrity in 
cdh23 mutants 
As a final point of analysis, I wanted to see the effects of inhibiting both the 
Perk and Ire1 pathways in cdh23 mutants by treating the cdh23;eiF2α double mutants 
and siblings with Losmapimod at 3 dpf for 48 hrs (Figure 26).  
 
Using the same strategies as above, I counted the total numbers of hair bundles 
and hair cells and analyzed the hair bundle phenotypes (Figure 27). I did not find a 
significant change in the numbers of hair bundles and hair cells in treated cdh23;eiF2α 
double mutants and siblings (Figure 27A,B) nor did I find a rescue of hair bundle 
morphology (Figure 26 and 27C). It is interesting to note that in larvae treated with 
Losmapimod, the amount of wild-type like hair bundles is decreased to the level of the 
 
Figure 26: Actin labeling of the anterior macula. DMSO treated siblings (A), cdh23 mutants (B) and cdh23; 
eiF2α double mutants (C). Losmapimod treated siblings (D), cdh23 mutants (E) and cdh23; eiF2α double  
mutants (F).  Scale bar: 10 µm. 
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untreated cdh23 mutant, suggesting that with the current conditions, the Losmapimod 
might affect hair bundle morphology. 
 
 
 
Figure 27: Quantification of anterior macula phenotypes. Graphs representing the numbers of hair bundles (A), 
hair cells (B). Bold numbers are average numbers of hair bundles (A) and hair cells (B) per larvae. Hair bundle 
phenotypes in DMSO and Losmapimod (LOSMA) treated cdh23 mutants, cdh23;eiF2α double mutant and siblings 
larvae (C). ns = not significant.  
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4. Discussion 
Past research on USH1 using zebrafish as a model system has provided essential 
information to comprehend the mechanisms leading to the disease. The discovery that 
ER stress might be the cause of some of the USH1 symptoms has allowed me to explore 
new possibilities of treatments.  
This thesis looked specifically at one USH1 zebrafish gene, cdh23, and aimed 
first, to investigate the ER stress related pathways activated due to this mutation, and 
second, to test FDA approved drugs that would target these pathways and assay for 
rescue of the observed cdh23 mutant phenotypes.  
 
4.1 Activation of the UPR pathways in inner ear hair cells and retinal cells of cdh23 
mutants 
Here I have presented preliminary data that indicate that the Perk signaling 
pathway is activated in the inner ear hair cells of 5 dpf cdh23 mutants. Our data support 
the finding in Cdh23 mutant mice (Hu et al., 2016). Our results also show that the Ire1 
pathway is likely activated in these cells. It is important to point out that my 
experiments were run at only one time point. It is possible that with development and 
continued ER stress, the Ire1 pathway becomes activated leading to an increase in levels 
of phosphorylated Ire1. To test this, we would need to look at the activation of the Ire1 
pathway at later stage of development.  
In the retina, I found that the Perk pathway is activated in cdh23 mutants. The 
significant decrease in the total amount of Ire1 protein in the cdh23 mutants could also 
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reflect the activity of the Perk pathway, as it is known to attenuate translation (Kim et 
al., 2008). However, I cannot rule out that the Ire1 pathway is not activated at later 
stages of development. Past research has shown that photoreceptor death within the 
retina is increased at 8 dpf in ush1c zebrafish (Phillips et al., 2011). Therefore, more 
research and adjustment of experimental conditions may be necessary.  
Another reason why the Ire1 pathway does not seem activated could be the high 
variability I observe between the larvae. Despite running the experiments in duplicate or 
triplicate, the sample size is still small. By increasing the number of mutants and 
siblings for each condition, I would have a more representative measurement of what is 
occurring in the cdh23 population.  
4.2 Effect of FDA approved drugs on inner ear hair cells in cdh23 mutants 
I found that the increase in ER stress observed in the cdh23 mutants can be 
diminished by addition of SP600125, a FDA approved drug inhibiting the JNK branch 
of the Ire1 pathway. These results support the hypothesis that the Ire1 pathway might be 
activated in the inner ear hair cells. Addition of Losmapimod which inhibits another 
branch (MAPK) of the Ire1 pathway, did not have such an effect, suggesting that, at this 
stage of development, this part of the Ire1 pathway is not activated. Applying the drugs 
at variable stages of development and/or adjusting their concentration may have a 
greater effect on hair bundle morphology or even behavior. 
With the current data, we do not know if the Ire1 and Perk pathways act together 
or independently. The third UPR pathway, Atf6, could also be affecting the phenotypes 
of cdh23 mutants. Because we are unsure at this point of how these three pathways 
interact, it is possible that affecting one pathway could lead to changes in another.  
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The findings from my research have important implications for both the future 
study and potential treatment for USH1. Additional research building from these results 
will give an even better understanding of the molecular mechanisms leading to USH1 
and the potential treatment of this syndrome. 
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5. Future Directions 
Overall, the results from this study have increased our understanding of the 
mechanisms underlying USH1, but it has also brought forth many new questions and 
points of future research regarding CDH23 and other USH1 genes. 
 The third UPR pathway, Atf6, has not been investigated in ush1 zebrafish 
mutants. To build on our understanding of the effects of these pathways on USH1 
phenotypes, we could investigate the effects of this pathway as well as its interaction 
with Ire1 and Perk.  
 It would also be interesting to look at other FDA approved drugs that affect 
other parts of the UPR pathways and see if it results in a rescue of the ush1 mutant cell 
death level, phenotypes, and behavior. For example, the Ire1 pathway breaks into three 
separate pathways (Kim et al., 2008). I investigated two of them here, the MAPK and 
the JNK pathways. The third pathway is an RNAse splicing pathway, which can be 
affected by other drugs (Kim et al., 2008). Toyocamycin has been shown to inhibit ER 
stress by blocking this latter pathway in human epithelial cells with multiple myeloma 
in vitro (Ri et al., 2012). Using drugs like Toyocamycin that target other parts of the 
UPR pathways may shed more light on the exact mechanism that leads to phenotypes of 
USH1 in zebrafish and in human patients. The work on SP600125 is definitely worth 
pursuing. 
Finally, it would be valuable to investigate if the results obtained here are 
consistent across the various USH1 zebrafish mutants (ush1c, cdh23, myo7aa and 
pcdh15a).  
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